Simon Dryden

Simon Dryden

Auto-generated profile, based on publicly available information

Simon Dryden

Institute of Global Health Innovation, Imperial College London, London, UK

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 January 2025 in Journal of Infection
Verified
Journal Article
Open access
ALAkish Luintel
Akish Luintel
JHJoseph Healy
Joseph Healy
MBMichael Blank
Michael Blank
ALAashika Luintel
Aashika Luintel
SDSimon Dryden
Simon Dryden
GCGraham Cooke
Graham Cooke
Patients labelled with penicillin allergy (PenA) often receive broader spectrum antibiotics, associated with antimicrobial resistance and poorer outcomes. However, ∼95% of patients are likely mis-labelled. Whilst de-labelling programmes are gaining momentum, they have been restricted to a few countries. Here, we address the global prevalence of PenA, to inform the wider potential impact for de-labelling programmes. We conducted a systematic review and meta-analysis including all studies on adult PenA prevalence between January 2003 and June 2023. Data on PenA prevalence, allergy recording methods, healthcare setting, and country income were extracted. This study is registered on PROSPERO (CRD42023437718). 174 studies from 28 countries were included (18,352 screened). Global PenA prevalence was 9·4% (95% CI 8·4-10·4%). 92% of peer-reviewed publications were from high-income countries(HICs), with 72% from the UK, USA or Australia. HICs had higher PenA prevalence 9·9% (95% CI 8·8-11·0%), compared to middle-income countries (MICs), 4·4% (95% CI 2·8-6·2%), p<0.0001. Primary care data was seldom reported (16% of studies), and the method of allergy recording significantly influenced reported prevalence. Studies reporting PenA prevalence are skewed towards HICs and secondary care, with little data from Africa, most of Asia and South America. This highlights an unmet need to broaden epidemiological analysis in under-represented regions.

19 February 2026 in JMIR Infodemiology
Verified
Journal Article
Open access
FCFangyue Chen
Fangyue Chen
TTTricia Tay
Tricia Tay
HTHannah Thould
Hannah Thould
CNChatchaya Nangsue
Chatchaya Nangsue
SDSimon Dryden
Simon Dryden
KGKate Grailey
Kate Grailey
Background: Social media has transformed the landscape of health communication. Video content can optimally activate our cognitive systems, enhance learning, and deliver accessible information. Evidence has suggested the positive impact of videos on health knowledge and health-related behaviors, yet the impact of social media videos on quantitative health outcomes is underresearched. Evaluating such outcomes poses unique challenges in measuring exposure and outcomes within internet-based populations. Objective: We aimed to evaluate the impact of social media videos on quantitative health outcomes, examine methodologies used to measure these effects, and describe the characteristics of video interventions and their delivery. Methods: In accordance with PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines, MEDLINE, Embase, Web of Science, CINAHL, and Google Scholar were searched. Studies were eligible if they were original research evaluating long-form social media video interventions addressing any health-related condition, delivered via social media platforms, and reported quantitative health outcomes. The primary outcome was the effect of social media videos on quantitative health outcomes. Additional outcomes included participant characteristics, video features, delivery methods, and the use of theoretical frameworks. A narrative synthesis was conducted. A subgroup meta-analysis was performed to synthesize health outcomes mentioned in 2 or more studies with sufficient homogeneity. Risk of bias assessment was conducted using Cochrane Risk of Bias 2, ROBINS-I, or National Institutes of Health Quality Assessment Tool, depending on the study design. One reviewer screened titles and abstracts. Two reviewers independently conducted full-text screening, data extraction, and risk of bias assessment. Results: A systematic search was conducted on October 25, 2023, and was updated on June 12, 2025, yielding a total of 41,172 records after duplicate removal. Sixteen studies were included, involving 4158 participants. Mental health–related conditions were the most studied (10 studies). Most video interventions were delivered via YouTube (12 studies). Studies have reported that video interventions were associated with significant improvements in peri-procedural anxiety, mood, and physical activity levels, although most findings were limited to individual studies with variable methodological quality. Three studies that developed videos with user input and theoretical frameworks significantly impacted study-specific primary outcomes. A subgroup meta-analysis demonstrated a significant moderate impact of online video interventions in improving peri-procedural anxiety (standard mean difference=0.57, 95% CI 0.09‐1.05). All but one study showed some concern or high risk of bias. Conclusions: We demonstrated a potential positive impact of social media videos on quantitative health outcomes, notably in improving peri-procedural anxiety. Videos developed with user input and theoretical frameworks significantly impacted study-specific primary outcomes. Nevertheless, there is the need to shift focus toward measuring physical health–related outcomes and to develop better designed, innovative methodologies to measure the impact that can better simulate the social media environment.

30 January 2026 in Digital Health
Verified
Journal Article
Open access
TTTricia Tay
Tricia Tay
KGKate Grailey
Kate Grailey
FCFangyue Chen
Fangyue Chen
HAHamzah Amin
Hamzah Amin
BMBalraj Maan
Balraj Maan
ADAra Darzi
Ara Darzi
Introduction: Frailty is defined as a clinically recognised state of increased vulnerability, reflecting a decline in an individual's psychological and physical reserves. Digitally-enabled interventions are increasingly utilised to monitor and support the health of older adults. Evidence on the effectiveness of digitally-enabled interventions in reducing frailty is limited. This systematic review aimed to investigate the types of digitally-enabled interventions tested, with what goals with respect to frailty, and the resulting outcomes. Method: Medline, CINAHL, Scopus, PsychInfo and Embase were searched from time of origin until July 2024. Peer-reviewed RCTs assessing the impact of digitally-enabled interventions on older adults were included. Outcome measures explored were frailty, cognitive status, mental health, quality of life, adherence and usability. Data was extracted independently by two people using Covidence platform. Narrative synthesis was performed for all studies and meta-analysis was performed for outcomes reported in four or more studies. Results: From 4476 titles and abstracts screened, 17 studies were included following full text review. Overall, 12 studies included exercises as a component or the sole form of intervention. The mean duration of intervention was 4.04(SD2.56) months. Mean adherence to the intervention was 59% which was lower in exercise-based intervention. The most and least reported frailty-specific outcome was walking speed ( n = 8) and self-reported exhaustion level ( n = 2). Meta-analysis showed non-exercise-based interventions showed significant improvements in SPPB. There was no statistically significant change in Timed-up and Go and handgrip strength. Narrative synthesis indicates there was insufficient evidence to evaluate the impact of digital interventions on frailty, frailty-specific outcomes, mental health, activities of daily living, health-related quality of life, sleep and cognition. Conclusion: The findings suggest low technological readiness and adherence among digitally-enabled interventions for older adults. Narrative synthesis of overall frailty and outcome measures showed mixed results and limited evidence on the impact of digital interventions on frailty and outcomes.

14 February 2020
Verified
Conference Paper
Open access
PDF file
SDSimon D. Dryden
Simon D. Dryden
SASalzitsa Anastasova
Salzitsa Anastasova
GSGiovanni Satta
Giovanni Satta
ATAlex Thompson
Alex Thompson
DLDaniel R. Leff
Daniel R. Leff
ADAra W. Darzi
Ara W. Darzi
150 million people worldwide suffer one or more urinary tract infections (UTIs) annually. UTIs are a significant health burden: societal costs of UTI exceed $3.5 billion in the U.S. alone; 5% of sepsis cases arise from a urinary source; and UTIs are a prominent contributor toward antimicrobial resistance (AMR). Current diagnostic frameworks exacerbate this burden by providing inaccurate and delayed diagnosis. Rapid point-of-care bacterial identification will allow for early precision treatment, fundamentally altering the UTI paradigm. Raman spectroscopy has a proven ability to provide rapid bacterial identification but is limited by weak bacterial signal and a susceptibility to background fluorescence. These limitations may be overcome using surface enhanced Raman spectroscopy (SERS), provided close and consistent application of bacteria to the SERS-active surface can be achieved. Physical filtration provides a means of capturing uropathogens, separating them from the background solution and acting as SERS-active surface. This work demonstrates that filters can provide a means of aggregating bacteria, thereby allowing subsequent enhancement of the acquired Raman signal using metallic nanoparticles. 60 bacterial suspensions of common uropathogens were vacuum filtered onto commercial polyvinylidene fluoride membrane filters and Raman signals were enhanced by the addition of silver nanoparticles directly onto the filter surface. SERS spectra were acquired using a commercial Raman spectrometer (Ocean Optics, Inc.). Principal Component – Linear Discriminant Analysis provided discrimination of infected from control samples (accuracy: 88.75%, 95% CI: 79.22-94.59%, p-value <0.05). Amongst infected samples uropathogens were classified with 80% accuracy. This study has demonstrated that combining Raman spectroscopy with membrane filtration and SERS can provide identification of infected samples and rapid bacterial classification.

11 December 2025 in JMIR Medical Informatics
Verified
Journal Article
Open access
RBRiley Bove
Riley Bove
LCLuca Capezzuto
Luca Capezzuto
IWImogen West
Imogen West
SDSimon Dryden
Simon Dryden
SGSaira Ghafur
Saira Ghafur
AKAgne Kazlauskaite
Agne Kazlauskaite
Background: Efforts are being made to integrate digital health technologies into clinical care for multiple sclerosis (MS) to improve patient monitoring. Efficiently probing how they might impact clinical care could streamline digital tool development. The Floodlight digital tool, comprising 5 smartphone sensor–based tests, was used to generate health-related data on patient function and symptoms in a clinical simulation. Objective: The study had 3 objectives: (1) assess the utility of simulated clinical encounters as a research methodology for exploring the introduction of digital health technologies into clinical practice in MS, (2) confirm the fidelity of the simulated environment and patient cases developed and understand what metrics (eg, workflow, comprehensive evaluation) could be generated, and (3) generate insights into the utility of digitally collected data, including usability, clinical decision contribution, and impact on workflows, in clinical practice. Methods: A total of 2 patient cases consisting of clinical, radiological, and digital health data were developed with clinician input. US-based neurologists prepared for and conducted 2 simulated teleconsultations each, with an actor briefed on case profiles. Floodlight data were available, via the Floodlight MS™ Health Care Professional Portal, for 1 of the 2 consultations. Participant neurologists completed interviews and surveys assessing the fidelity of the cases presented, user experience and workflow metrics, patient concerns identified, care decisions made, and confidence in making decisions. Results: All 10 neurologists indicated that the simulations were high-fidelity representations of real consultations. Using the Floodlight technology for the first time, median time taken to prepare for and conduct the consultation was ~1.7‐2 minutes longer, with slightly greater mental effort reported by participants, compared with not using the tool. The Floodlight MS Health Care Professional Portal scored an “above average” 79 on the System Usability Scale and an “acceptable” Net Promoter Score of 10. In total, 6 of the 10 neurologists “strongly agreed” that it was easier and quicker to identify patient concerns when they had access to the patient-generated Floodlight data to prepare for their encounters than when they did not. Overall, more care and management decisions were taken when the digital tool was used (37 vs 29). Of those 37 decisions, Floodlight data were reported as a trigger for 20 decisions, always in combination with other elements including patient history (20/20) and clinical exam findings (9/20). Conclusions: These findings advance our understanding of clinical simulation as a method for evaluating digital tools and other innovative technologies for MS care. High-fidelity patient cases could be provided for the mock teleconsultations, and the simulated clinical environment was useful for evaluating usability and utility of a new digital tool—yielding preliminary evidence on how digital data could be accessed and utilized by neurologists to support routine MS care.

15 February 2026 in JMIR Preprints
Verified
Preprint
Open access
YGYasmin Grant
Yasmin Grant
CHChik Wai Ho
Chik Wai Ho
SAStephanie Archer
Stephanie Archer
SDSimon Dryden
Simon Dryden
Daniel LeffDaniel Leff
Daniel Leff
ECEmma V Carrington
Emma V Carrington
BACKGROUND It is increasingly common that patients are given the option to receive health information using digital technology. Augmented reality (AR) is an emerging technology which may enable patients to better appreciate anatomy pertinent to their disease process. OBJECTIVE Our objective was to understand patients’ perspectives about augmented reality in the context of shared decision making (SDM) for oncoplastic breast surgery. METHODS Three focus groups with a total of 17 participants without breast cancer were recruited from general surgery out-patient clinics in a university teaching hospital. Participants interacted with a Microsoft HoloLens 2™ head-mounted display presenting an anonymised three-dimensional holographic model of a breast cancer, which was used as a stimulus to prompt discussion. Anonymised interview audio transcripts were transcribed verbatim and analysed using thematic analysis. RESULTS Analysis revealed four themes: 1) Seeing as believing – AR enhanced participants ability to visualise abstract anatomy and aid understanding, 2) Being in the surgeon’s shoes – the technology offered insight into the clinicians perspective, with concerns raised about the emotional impact, 3) How technology influences trust – AR reinforced confidence in the shared decision-making process when introduced by trusted clinicians, 4) Involving people in my life – shared viewing with family or friends offered support in the decision-making process. CONCLUSIONS Participants viewed AR as a promising tool to enhance knowledge and add value in the process of SDM beyond the reach of current information giving. They also expressed caution, emphasising the need for careful introduction and ongoing clinician support to ensure meaningful use. Their varied responses highlighted the challenge inherent to introduction of digital technologies such as AR – the question of how much, and what type of technology best supports patients without causing information overload. Trust in clinicians remained central to the perceived value of the technology. These findings highlight AR’s potential to enhance SDM when thoughtfully integrated into clinical practice. CLINICALTRIAL N/a